Galenica Sustainability and Business Performance
About Galenica
Market environment
Business performance
Governance
Sustainability
Outlook
Swiss Healthcare Market:
Regulatory environment
Topic / Initiative
Reduction in drug
prices
Generics prices
,,Reference price system"
08/08/22
Generics
Direct import
Distribution margin /
SBR V
OTC products1:
online trade
1 Swissmedic category D
Current status
Standard process, FOPH verifies drug prices in a three-year cycle
-
Price reduction round for 2021 completed
Initiative is definitely rejected (Dec 2021)
-
Initiative is definitely rejected (Feb 2022)
-
-
Proposal of SBR V contract and distribution margin model still under discussion
New proposal for distribution margin by FOPH, consultation started in 2022
New consultation of A. Berset regarding distribution margin, generic promotion and price
reductions launched on 3 June 2022
Implementation of a new model at earliest by mid 2023
Federal Council will present a proposal, consultation starting in 2023
Implementation of a new law at earliest in 2024
34
GALENICAView entire presentation